Ultragenyx Pharmaceutical Inc. (RARE)

Healthcare · Biotechnology · NASDAQ

Ultragenyx Pharmaceutical Inc. (RARE) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.55B and a free-cash-flow yield of -19.1%. Over the most recent reported fiscal year, revenue grew 20.2%.

Market cap	$2.55B
Trailing P/E	—
FCF yield	-19.1%
Revenue growth (YoY)	+20.2%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live RARE data on Nama Insights →

Recent Congressional trades

Ultragenyx Pharmaceutical Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Apr 6, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Aug 13, 2025